麻豆传媒

Based in New York City, Dr. Raphael Kellman, MD, is a Physician of Integrative and Functional Medicine and founder of Kellman Wellness Center, a premier functional and holistic medical practice.

Dr. Kellman pioneered a groundbreaking new brand of medicine and healing called 鈥淢icrobiome Medicine,鈥� and through his deep understanding of the importance of the microbiome, Dr. Kellman treats gastrointestinal issues, chronic fatigue syndrome, heart disease, autoimmune disorders, Lyme disease, cancer, autism spectrum disorders, and unexplained, unresolved health issues.

Dr. Kellman was the first doctor to recognize the profound importance of the microbiome. In addition to providing patient care, Dr. Kellman publishes and lectures, advocating for whole-patient care and discussing his cutting-edge approach to curing illness through healing the microbiome. He is the author of the best-selling 鈥淢icrobiome Diet,鈥� 鈥淭he Microbiome Breakthrough,鈥� and his latest release "Microbiome Thyroid."

The Alcaide lab at Tufts University School of Medicine combines the areas of immunology, vascular biology, and cardiac physiology to study the adaptive immune response in diverse inflammatory settings, with a particular focus on the heart in the context of heart failure. The over-arching goal of the lab is to better understand the molecular and cellular mechanisms taking place during T lymphocyte trafficking and how those can potentially be targeted in therapeutically useful ways. The Alcaide lab uses several in vivo mouse models of heart failure to study the T cell immune responses involved in cardiac pathophysiology, combined with a broad range of immunological approaches. T cell crosstalk with endothelial cells are studied using in vitro flow systems and real time video microscopy, and they use additional state of the art approaches to investigate the implications of T cell responses on cardiac resident cells.